Tag Archive for: Collaboration

DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration

/in

Dalton is a drug discovery platform integrating agentic AI, human expertise, and experimental data, into one continuous learning engine Announces collaboration with Sygnature Discovery, a leading integrated drug discovery contract research organisation (CRO), as a client London, UK – 4 June 2026 – DaltonTx, the intelligence backbone for modern drug discovery: connecting AI, human expertise and […]

Read more

Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics

/in

Collaboration combines Bonito’s proprietary functional delivery data engine and ligand discovery platform with DaltonTx’s adaptive AI technology to accelerate precision oligotherapeutic delivery, beginning in the CNS Waltham, MA and London, UK – May 27th, 2026 – Bonito Biosciences (“Bonito”), a biotechnology company building the data foundation for programmable oligotherapeutic delivery, and”) DaltonTx, the intelligence backbone […]

Read more

Women in Life Science Denmark (WiLD) expands Nordic footprint with launch of WiLD Finland

/in

WiLD strengthens Nordic collaboration across Denmark, Finland, Norway and Sweden Copenhagen, Denmark / Helsinki, Finland, 21 January 2026: Women in Life Science Denmark (WiLD), the Nordic non-profit network dedicated to advancing women into senior leadership positions in life sciences, today announces the launch of WiLD Finland. WiLD’s expansion further strengthens its ambition to contribute to […]

Read more

Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering

/in

Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTM  London, UK and Chicago, IL – 15 December 2025 – Leucid Bio (“Leucid” or the “Company”), a privately-held biotechnology company developing innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using its proprietary lateral CAR platform, and Syenex, an open-science genetic medicines platform company, today announced a strategic collaboration […]

Read more

Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies

/in

Leverages Kling’s technology to discover hard-to-find, immuno-functional antibodies from immortalized human B cells Accelerating discovery of first-in-class antibodies to transform disease prevention and treatment Amsterdam, NLD – 24 July 2025 – Kling Bio (“Kling” or “the Company”), a biotech company developing antibody-based drugs for cancer and infectious diseases, today announced it has entered into a […]

Read more
© Optimum Strategic Communications.